Auflistung nach Autor "Nahidino, Philipp"

Anzeige der Dokumente 1-3 von 3

An updated patent review of p38 MAP kinase inhibitors (2014-2019)

Haller, Vanessa; Nahidino, Philipp; Forster, Michael; Laufer, Stefan (2020)
Bioisosteric Replacement of Arylamide-Linked Spine Residues with N-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38 alpha MAP Kinase Inhibitors

Nahidino, Philipp; Kudolo, Mark; Pantsar, Tatu; Forster, Michael; Laufer, Stefan (2020)
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer

Rudalska, Ramona; Harbig, Jule; Forster, Michael; Esposito, Aylin; Kudolo, Mark; Botezatu, Adelina; Haller, Vanessa; Janssen, Nicole; Holzmayer, Samuel; Nahidino, Philipp; Trompak, Omelyan; Pantsar, Tatu; Kronenberger, Thales; Yurttas, Can; Rist, Elke; Weber, Alexander N. R.; Rothbauer, Ulrich; Schwab, Matthias; Singer, Stephan; Zender, Lars; Laufer, Stefan; Wölffing, Pascal; Königsrainer, Alfred; Märklin, Melanie; Mürdter, Thomas E.; Dauch, Daniel Alexander (2025)

Anzeige der Dokumente 1-3 von 3

Stöbern